Background: A potential drug interaction exists between oral corticosteroids and warfarin, but there is limited documentation. Objective: To evaluate the potential drug interaction between oral ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...

Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

WASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...

It provides additional substantiation to existing data of a drug class interaction between oral anticoagulants and corticosteroids. The interaction resulted in a significant increase in INR for ...

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

Therefore, it’s important to closely monitor patients after they begin a treatment regimen and adjust accordingly. Oral corticosteroids are anti-inflammatory medications that are the mainstay ...

Buying steroids in the USA requires careful attention to legality, quality, and source reliability. Opt for reputable brands ...

Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...

LUNA data combined with follow-up from OPTIC at 4 years continue to support long-term potential best-in-class product profile of ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...